VYNE Therapeutics Inc. - VYNE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | CHIEF FINANCIAL OFFICER | F | D | 3,464.0 | 0.6507 | 2,254.02 | 97,434.0 | View | |
| Jul 02, 2026 | CHIEF LEGAL OFFICER AND GC | F | D | 3,464.0 | 0.6507 | 2,254.02 | 118,434.0 | View | |
| Jul 02, 2026 | CHIEF SCIENTIFIC OFFICER | F | D | 2,370.0 | 0.6507 | 1,542.16 | 111,349.0 | View | |
| Jul 02, 2026 | PRESIDENT AND CEO | F | D | 12,214.0 | 0.6507 | 7,947.65 | 426,565.0 | View | |
| Jun 02, 2026 | PRESIDENT AND CEO | A | A | 30,791.0 | 0.31 | 9,545.21 | 438,779.0 | View | |
| Apr 02, 2026 | CHIEF LEGAL OFFICER AND GC | F | D | 4,007.0 | 0.5975 | 2,394.18 | 121,898.0 | View | |
| Apr 02, 2026 | CHIEF SCIENTIFIC OFFICER | F | D | 2,876.0 | 0.5975 | 1,718.41 | 112,363.0 | View | |
| Apr 02, 2026 | CHIEF FINANCIAL OFFICER | F | D | 4,007.0 | 0.5975 | 2,394.18 | 99,788.0 | View | |
| Apr 02, 2026 | PRESIDENT AND CEO | F | D | 14,232.0 | 0.5975 | 8,503.62 | 401,976.0 | View |